Vis enkel innførsel

dc.contributor.authorMartiniussen, Marit Almenning
dc.contributor.authorLarsen, Marthe
dc.contributor.authorHovda, Tone
dc.contributor.authorKristiansen, Merete U.
dc.contributor.authorDahl, Fredrik Andreas
dc.contributor.authorEikvil, Line
dc.contributor.authorBrautaset, Olav
dc.contributor.authorBjørnerud, Atle
dc.contributor.authorKristensen, Vessela N.
dc.contributor.authorBergan, Marie Burns
dc.contributor.authorHofvind, Solveig Sand-Hanssen
dc.date.accessioned2025-08-06T09:30:41Z
dc.date.available2025-08-06T09:30:41Z
dc.date.issued2025-02-05
dc.description.abstractTwo deep learning–based artificial intelligence (AI) models, one commercially available and one in-house, showed good performance for stand-alone cancer detection on retrospective mammography screening data. AI markings on the mammograms corresponded well to the true cancer location.<p> <p>Purpose - To evaluate cancer detection and marker placement accuracy of two artificial intelligence (AI) models developed for interpretation of screening mammograms.<p> <p>Materials and Methods - This retrospective study included data from 129 434 screening examinations (all female patients; mean age, 59.2 years ± 5.8 [SD]) performed between January 2008 and December 2018 in BreastScreen Norway. Model A was commercially available and model B was an in-house model. Area under the receiver operating characteristic curve (AUC) with 95% CIs were calculated. The study defined 3.2% and 11.1% of the examinations with the highest AI scores as positive, threshold 1 and 2, respectively. A radiologic review assessed location of AI markings and classified interval cancers as true or false negative.<p> <p>Results - The AUC value was 0.93 (95% CI: 0.92, 0.94) for model A and B when including screen-detected and interval cancers. Model A identified 82.5% (611 of 741) of the screen-detected cancers at threshold 1 and 92.4% (685 of 741) at threshold 2. Model B identified 81.8% (606 of 741) at threshold 1 and 93.7% (694 of 741) at threshold 2. The AI markings were correctly localized for all screen-detected cancers identified by both models and 82% (56 of 68) of the interval cancers for model A and 79% (54 of 68) for model B. At the review, 21.6% (45 of 208) of the interval cancers were identified at the preceding screening by either or both models, correctly localized and classified as false negative (n = 17) or with minimal signs of malignancy (n = 28).<p> <p>Conclusion - Both AI models showed promising performance for cancer detection on screening mammograms. The AI markings corresponded well to the true cancer locations.en_US
dc.identifier.citationMartiniussen, Larsen, Hovda, Kristiansen, Dahl, Eikvil, Brautaset, Bjørnerud, Kristensen, Bergan, Hofvind. Performance of Two Deep Learning–based AI Models for Breast Cancer Detection and Localization on Screening Mammograms from BreastScreen Norway. Radiology: Artificial Intelligence (RAI). 2025;7(3)en_US
dc.identifier.cristinIDFRIDAID 2391664
dc.identifier.doi10.1148/ryai.240039
dc.identifier.issn2638-6100
dc.identifier.urihttps://hdl.handle.net/10037/37913
dc.language.isoengen_US
dc.publisherRadiological Society of North America (RSNA)en_US
dc.relation.journalRadiology: Artificial Intelligence (RAI)
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2025 The Author(s)en_US
dc.titlePerformance of Two Deep Learning–based AI Models for Breast Cancer Detection and Localization on Screening Mammograms from BreastScreen Norwayen_US
dc.type.versionacceptedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel